Amphastar is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and ...

Most of this rise was associated with the expansion of the sales force for recently purchased BAQSIMI. Revenues rose nearly six percent on a year-over-year basis to $191.2 million, some $3 million ...

There was no effect of insulin in the larger cohort using the second device. In a subsequent Phase 2 study to determine how much insulin entered the brain after nasal delivery, 19 people received 40 ...